Valuation: The Cooper Companies, Inc.

Capitalization 16.14B 13.94B 12.93B 12.09B 22.46B 1,464B 24.19B 149B 58.77B 698B 60.52B 59.28B 2,549B P/E ratio 2026 *
27.2x
P/E ratio 2027 * 22.9x
Enterprise value 18B 15.55B 14.43B 13.48B 25.05B 1,632B 26.98B 166B 65.55B 778B 67.5B 66.11B 2,843B EV / Sales 2026 *
4.17x
EV / Sales 2027 * 3.85x
Free-Float
91.2%
Yield 2026 *
0.01%
Yield 2027 * 0.01%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.07%
1 week-1.29%
Current month+0.50%
1 month-0.13%
3 months+14.45%
6 months+12.44%
Current year+0.50%
More quotes
1 week 80.1
Extreme 80.105
84.36
1 month 80.1
Extreme 80.105
85.04
Current year 80.1
Extreme 80.105
85.04
1 year 61.78
Extreme 61.775
100.24
3 years 61.78
Extreme 61.775
112.38
5 years 61.05
Extreme 61.0538
115.9
10 years 29.82
Extreme 29.82
115.9
More quotes
Manager TitleAgeSince
Chief Executive Officer 56 30/04/2018
Director of Finance/CFO 47 30/04/2018
Chief Operating Officer 61 31/10/2013
Director TitleAgeSince
Director/Board Member 56 30/04/2018
Chairman 79 22/03/2021
Chairman 62 01/01/2026
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.07%-1.29%-11.69%-4.59% 16.14B
-3.90%-2.48%+11.02%+53.32% 145B
+0.35%+0.41%-17.15%-6.85% 39.15B
-1.42%-1.43% - - 8.63B
+10.52%+10.93%+153.78%+1,221.66% 3.72B
-1.26%+1.05%-1.80%-57.62% 2.11B
-2.01%+3.15%+17.59%+2.70% 1.29B
0.00%+0.31%+15.33%-38.43% 755M
-0.88%-1.74%-23.92%-36.55% 698M
Average +0.16%+0.35%+17.90%+141.71% 24.16B
Weighted average by Cap. -2.44%-1.57%+6.33%+56.30%
See all sector performances

Financials

2026 *2027 *
Net sales 4.32B 3.73B 3.46B 3.23B 6.01B 391B 6.47B 39.85B 15.72B 187B 16.19B 15.85B 682B 4.55B 3.93B 3.65B 3.41B 6.33B 413B 6.82B 42B 16.57B 197B 17.06B 16.71B 718B
Net income 536M 463M 430M 402M 746M 48.62B 804M 4.95B 1.95B 23.18B 2.01B 1.97B 84.67B 661M 571M 529M 495M 920M 59.91B 990M 6.1B 2.41B 28.57B 2.48B 2.43B 104B
Net Debt 1.86B 1.61B 1.49B 1.39B 2.59B 169B 2.79B 17.18B 6.78B 80.49B 6.98B 6.84B 294B 1.35B 1.17B 1.09B 1.01B 1.89B 123B 2.03B 12.5B 4.93B 58.57B 5.08B 4.97B 214B
More financial data * Estimated data
Logo The Cooper Companies, Inc.
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Employees
15,000
More about the company
Date Price Change Volume
16/01/26 82.37 $ +0.07% 3,501,330
15/01/26 82.31 $ +0.76% 2,427,743
14/01/26 81.69 $ -0.01% 2,695,522
13/01/26 81.70 $ -1.84% 1,623,220
12/01/26 83.23 $ -0.26% 3,274,236

Delayed Quote Nasdaq, January 16, 2026 at 09:00 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
82.37USD
Average target price
91.00USD
Spread / Average Target
+10.48%
Consensus

Quarterly revenue - Rate of surprise